
Sign up to save your podcasts
Or
The Chinese AI company doesn’t want to bother with funding—at least not right now. WSJ reporter Rebecca Feng discusses why DeepSeek is so hesitant. Plus, how will federal funding cuts impact drug development? WSJ enterprise technology bureau chief Steven Rosenbush explains the impact on the bioscience industry. Shara Tibken hosts.
Sign up for the WSJ's free Technology newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4.3
15681,568 ratings
The Chinese AI company doesn’t want to bother with funding—at least not right now. WSJ reporter Rebecca Feng discusses why DeepSeek is so hesitant. Plus, how will federal funding cuts impact drug development? WSJ enterprise technology bureau chief Steven Rosenbush explains the impact on the bioscience industry. Shara Tibken hosts.
Sign up for the WSJ's free Technology newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4,327 Listeners
1,715 Listeners
8,638 Listeners
3,177 Listeners
439 Listeners
2,803 Listeners
661 Listeners
1,458 Listeners
1,022 Listeners
42 Listeners
1,277 Listeners
5,957 Listeners
1,544 Listeners
1,321 Listeners
593 Listeners
53 Listeners
151 Listeners
127 Listeners